Skin cancer patients not told about side effects of treatment (From East London and West Essex Guardian Series)
Send photos, video and news by texting GUARDIAN SERIES to 80360 (cost 10p), or email us
Skin cancer patients not told about side effects of treatment at Barts Health Trust
The health trust which runs Whipps Cross Hospital scored below the national average on almost all areas of cancer patient care and support, according to a national survey.
Barts Health Trust performed most poorly in areas of providing full information to cancer patients about their diagnosis and treatment, leaving them ranked second worst overall out of all NHS trusts in England.
According to the NHS England National Cancer Patient Experience Survey, a remarkably low 35 per cent of lung cancer patients said they were given written information about the operation they were going to have, compared to a 66 per cent national average.
Just 38 per cent of skin cancer patients at Barts Health Trust said they were told about the possible side effects of their treatment, compared to a national average of 57 per cent.
Only 24 per cent of Urologocial cancer patients said hospital staff gave them information on where they could get financial support.
Barts Health Trust consistently scored below the national average of the 155 trusts taking part but they did score highly in some areas.
All skin cancer patients said that staff gave them a complete explanation of what was going to be done and the Trust scored nearly 10 per cent above the national average on staff doing everything they could to control the pain of prostate cancer patients.
Many of Barts Health scores reflected a majority positive response from patients but their scores still fell in the lowest 20th percentile of the national survey results.
A spokeswoman for Barts Health Trust said: “We are very disappointed by the results of this survey.
We strive to provide the best quality care for all our patients all of the time and while we have made progress in some areas, it is clear that there is more that can, and must, be done to improve our cancer patients’ experience.”
Comments are closed on this article.